HIV Prevention 2020: a framework for delivery and a call for action

Slides:

Advertisements

Similar presentations

Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys Prof Deborah S.

Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Spontaneous aneurysm of the superficial temporal artery

Antimicrobial therapy to prevent or treat oral mucositis

Volume 6, Issue 7, Pages (July 2005)

Pharmacogenetics and future drug development and delivery

Volume 349, Issue 9057, Pages (April 1997)

Food systems, nutrition, health and the environment

Patterns of mortality by occupation in the UK, 1991–2011: a comparative analysis of linked census and mortality records Dr Srinivasa Vittal Katikireddi,

Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study Dr Brian G Williams, PhD, Somya Gupta, MA,

Thank God for Richard Dawkins?

Tinnitus Dr David Baguley, PhD, Don McFerran, FRCS, Prof Deborah Hall, PhD The Lancet Volume 382, Issue 9904, Pages (November 2013) DOI: /S (13)

Volume 2, Issue 4, Pages e151-e158 (April 2015)

Paediatric HIV-1 infection

Volume 13, Issue 12, Pages (December 2012)

Dr Josè Vitale, MD, Prof Luigi Boni, MD, Nazario Brumana, MD

Volume 2, Issue 12, Pages e530-e539 (December 2015)

Political factors behind US global AIDS programmes slow-down

Volume 1, Issue 3, Pages (August 2014)

HIV moments and pre-exposure prophylaxis – Authors' reply

Hormones and bones The Lancet Volume 349, Pages S20-S23 (March 1997)

Volume 3, Issue 7, Pages e307-e317 (July 2016)

Exploring the heart of the human heart

Gene therapy—where are we?

Strengthening capacity for health research in Africa

Volume 2, Issue 6, Pages (June 2015)

Prevention of suicide with regulations aimed at restricting access to highly hazardous pesticides: a systematic review of the international evidence

Volume 382, Issue 9906, Pages (November 2013)

Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study Dr Brian G Williams, PhD, Somya Gupta, MA,

Organisation of the care of patients with heart failure

The effect of explosive remnants of war on global public health: a systematic mixed- studies review using narrative synthesis Alexandra Frost, MSc, Prof.

Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study Nabihah Sachedina, MBBS, Prof.

Volume 379, Issue 9835, Pages (June 2012)

HIV myths should not be resuscitated

Resuscitation at birth and cognition at 8 years of age: a cohort study

Volume 5, Issue 8, Pages e417-e426 (August 2018)

James E Scriven, David G Lalloo, Graeme Meintjes

Volume 379, Issue 9821, Pages (March 2012)

Volume 3, Issue 7, Pages e289-e296 (July 2016)

Food systems, nutrition, health and the environment

Volume 13, Issue 12, Pages (December 2012)

Tobias Breidthardt, MD, Dr Mehdi Namdar, MD, Prof Bernhard Hess, MD

Cold water immersion: sudden death and prolonged survival

What would happen if we stopped vaccination?

Patterns of mortality by occupation in the UK, 1991–2011: a comparative analysis of linked census and mortality records Dr Srinivasa Vittal Katikireddi,

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

Volume 393, Issue 10171, Pages (February 2019)

Spontaneous aneurysm of the superficial temporal artery

Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.

Confessions of a journal junkie

Telling it like it isn't: truth and lies in a post-9/11 world

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries Dr Noreen.

Thank God for Richard Dawkins?

Volume 3, Issue 7, Pages e297-e306 (July 2016)

Low-technology approaches

Volume 3, Issue 2, Pages e94-e104 (February 2016)

Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD The Lancet

Volume 375, Issue 9722, Pages (April 2010)

Thank you to our diverse (but not diverse enough) reviewers

Volume 376, Issue 9734, Pages (July 2010)

Costs of eliminating HIV in South Africa have been underestimated

Spatial lifecourse epidemiology

Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people.

Children and adolescents with HIV

The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study

Restructuring physical micro-environments to reduce the demand for meat: a systematic review and qualitative comparative analysis Filippo Bianchi, MPhil,

Political factors behind US global AIDS programmes slow-down

HIV moments and pre-exposure prophylaxis

Deriving a practical framework for the evaluation of health apps

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

Presentation transcript:

HIV Prevention 2020: a framework for delivery and a call for action Dr Karl L Dehne, PhD, Gina Dallabetta, MD, David Wilson, PhD, Prof Geoff P Garnett, PhD, Prof Marie Laga, PhD, Elizabeth Benomar, MBA, Ade Fakoya, PhD, Rachel C Baggaley, MBBS, Lisa J Nelson, MD, Susan Kasedde, PhD, Alvaro Bermejo, MD, Mitchell Warren, PhD, Clemens Benedikt, PhD The Lancet HIV Volume 3, Issue 7, Pages e323-e332 (July 2016) DOI: 10.1016/S2352-3018(16)30035-2 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 1 Core results for HIV prevention by 2020 ART=antiretroviral therapy. NSP=needle syringe programme. OST=opioid substitution therapy. PrEP=pre-exposure prophylaxis. The Lancet HIV 2016 3, e323-e332DOI: (10.1016/S2352-3018(16)30035-2) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 2 A management framework for HIV prevention ART=antiretroviral therapy. The Lancet HIV 2016 3, e323-e332DOI: (10.1016/S2352-3018(16)30035-2) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 3 Core capacities needed in a national HIV prevention management team The Lancet HIV 2016 3, e323-e332DOI: (10.1016/S2352-3018(16)30035-2) Copyright © 2016 Elsevier Ltd Terms and Conditions